The Advancing Clinical Trial Readiness (ACTR) initiative seeks to improve the nation’s ability to conduct clinical trials safely, quickly, and equitably. The ACTR initiative will develop, evaluate, and integrate new tools and technologies to enable faster, less expensive, decentralized trials operating closer to/at points of care that are more representative across geography, age, gender, race, ethnicity, and socioeconomic status.

The ACTR program will require collaboration across a diverse set of organizations, firms, and institutions to reach the American public more effectively than has been done before, including traditionally unreached populations in the US. To reach this ambitious goal, ARPANET-H is interested in and greatly values stakeholder feedback on the following questions to learn and benefit from a broad range of perspectives.  

Learn more and apply here.